Cobalamin (B12) deficiency is frequently encountered in dogs and cats with chronic enteropathies (CE) and exocrine pancreatic insufficiency (EPI). B12 metabolism follows a complex array of carriers to be effectively absorbed which can be negatively impacted by intestinal inflammation and dysbiosis. In human patients oral supplementation is often utilized, while repeated parenteral injections is often […] Read more »
Cobalamin (B12) metabolism requires many complex pathways, in which a breakdown of any could lead to B12 deficiency. In a system that has many points for breakdown, having adequate B12 begins with a quality food source. Like vitamin D, animal protein is the primary source of B12 – a concern with vegan diets. Provided there is […] Read more »
It is well documented that cats and dogs with chronic enteropathies (CE), intestinal lymphoma, or exocrine pancreatic insufficiency are often cobalamin (B12) deficient (1,2). Problems with intrinsic factor binding to ileal receptors in the diseased tissue leads to B12 deficiency. Current supplementation protocol calls for repeated parenteral injections of hydroxycobalamin over 6 weeks bypassing the diseased tissue. […] Read more »
